Frequent intravitreal injections are vital to help many older Australians keep their eyesight, but the costs can be prohibitive. Insight...
Read moreDetailsA great golf swing won't be too good to you if you can't see where the ball ends up. Amercian...
Read moreDetailsKorea-based global pharmaceutical company Celltrion has announced approval from the Therapeutic Goods Administration (TGA) of Australia of its ophthalmic treatment...
Read moreDetailsAlexion, AstraZeneca rare disease treatment Ultomiris (ravulizumab rch) has become the first targeted treatment option to be reimbursed for people living...
Read moreDetailsMelbourne ophthalmologist Dr Elvis Ojaimi outlines his pre- and post-operative treatment regime for surgical patients, and why he reaches for...
Read moreDetailsResearchers at the National Institutes of Health (NIH) in the United States say they have developed eye drops that extend...
Read moreDetailsA biotech breakthrough with a strong Australian link will be giving about 25,000 people Down Under a little more hope....
Read moreDetailsThe Australian College of Optometry (ACO) has announced that its Certificate in Ocular Therapeutics (COT) will now run every two...
Read moreDetailsA gene therapy developed by scientists in the UK has been granted orphan drug designation by the US FDA and...
Read moreDetailsIn what is expected to be great news for about 20,000 Australians, ophthalmologists are now able to prescribe the first...
Read moreDetailsInsight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.
© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited
© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited